The psychosocial burden of HPV: A mixed-method study of knowledge, attitudes and behaviors among hpv+ women

Journal of Health Psychology

Volumn 15, Issue 2, 2010, Pages 279-290

  Daley, Ellen M ^a   Perrin, Karen M ^a   Mcdermott, Robert J ^a   Vamos, Cheryl A ^a   Rayko, Holly L ^a   Packing Ebuen, Jennifer Lee ^a   Webb, Candace ^b   Mcfarlane, Mary ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b National Women's Law Center   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cervical cancer; Genital warts; HPV; Pap smear; Psychosocial

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ANGER; ARTICLE; ATTITUDE TO HEALTH; CONDYLOMA ACUMINATUM; CONTACT EXAMINATION; CONTROL; COST OF ILLNESS; FEAR; FEMALE; HEALTH SURVEY; HUMAN; ILLNESS BEHAVIOR; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PSYCHOLOGIC TEST; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; SELF CONCEPT; SEXUALITY; SOCIAL PSYCHOLOGY; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADOLESCENT; ADULT; ANGER; CONDYLOMATA ACUMINATA; CONTACT TRACING; COST OF ILLNESS; FEAR; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; ILLNESS BEHAVIOR; INTERNAL-EXTERNAL CONTROL; INTERVIEW, PSYCHOLOGICAL; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREJUDICE; QUESTIONNAIRES; RISK FACTORS; SELF CONCEPT; SEXUAL PARTNERS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77950292073     PISSN: 13591053     EISSN: 14617277     Source Type: Journal    
DOI: 10.1177/1359105309351249     Document Type: Article

References (26)

1. Anhang, R., Wright, T. C., Smock, L., & Goldie, S. J. (2003). Women's desired information about Human Papillomavirus. Cancer, 100, 315-320.
2. Brown, D. R., Kjaer, S. K., Sigurdsson, K., Iversen, O.-E., Hernandez-Avila, M., Wheeler, C. M. et al. (2009). The impact of quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years. Journal of Infectious Diseases, 199, 926-935.
3. Centers for Disease Control and Prevention (CDC). (2007). Advisory Committee on Immunization Practices. http://www.cdc.gov/vaccines/recs/ACIP/ downloads/min-oct07.pdf (accessed 4 September 2008).
4. Centers for Disease Control and Prevention (CDC). (2008a). Genital HPV infection: CDC fact sheet. http://www.cdc.gov/std/HPV/STDFactHPV.htm (accessed 28 December 2008).
5. Centers for Disease Control and Prevention (CDC). (2008b). HPV vaccine information for young women. http://www.cdc.gov/std/hpv/STDFact-HPV-vaccine.htm (accessed 4 September 2008).
6. Charo, R. A. (2007). Politics, parents, and prophylaxis: Mandating HPV vaccination in the United States. New England Journal of Medicine, 356, 1905-1908.
7. Daley, E. M., Perrin, K. M., Vamos, C., Webb, C., Mueller, T., Packing-Ebuen, J. L. et al. (2008). HPV knowledge among HPV+ women. American Journal of Health Behavior, 32, 477-487.
8. Denny-Smith, T., Bairan, A., & Page, M. C. (2006). A survey of female nursing students' knowledge, health beliefs, perceptions of risk, and risk behaviors regarding Human Papillomavirus and cervical cancer. Journal of the America Academy of Nurse Practitioners, 18, 62-69.
9. Food and Drug Administration (FDA). (2006). GARDASIL® Questions and answers. http://www.fda.gov/cber/products/hpvmer060806qa.htm (accessed 5 May 2009).
10. Gerhardt, C. A., Pong, K., Kollar, L. M., Hillard, P. J. A., & Rosenthal, S. L. (2000). Adolescents' knowledge of Human Papillomavirus and cervical dysplasia. Journal of Pediatric and Adolescent Gynecology, 13, 15-20.
11. Gravitt, P. E., & Shah, K. V. (2005). A virus-based vaccine may prevent cervical cancer. Current Infectious Disease Reports, 7, 125-131.
12. Holcomb, B., Bailey, J. M., Crawford, K., & Ruffin, M. T. (2004). Adults' knowledge and behaviors related to Human Papillomavirus infection. Journal of the American Board of Family Practitioners, 17, 26-31.
13. Kahn, J. A., Slap, G. B., Bernstein, D. I., Kollar, L. M., Tissor, M., Hillard, P. A. et al. (2005). Psychological, behavioral, and interpersonal impact of Human Papillomavirus and Pap test results. Journal of Women's Health, 14, 650-659.
14. Maissi, E., Marteau, T. M., Hankins, M., Moss, S., Legood, R., & Gray, A. (2004). Psychological impact of Human Papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: Cross sectional questionnaire study. British Medical Journal, 328, 1293-1296.
15. Massad, L. S., Verhulst, S. J., Hagemeyer, M., & Brady, P. (2006). Knowledge of the cervical cancer screening process among rural and urban Illinois women undergoing colposcopy. Journal of the Lower Genital Tract Disease, 10, 252-255.
16. McCaffery, K., Waller, J., Nazroo, J., & Wardle, J. (2006). Social and psychological impact of HPV in cervical screening: A qualitative study. Sexually Transmitted Infectections, 82, 169-174.
17. Merck & Co., Inc. (2007). A randomized, international, double-blinded (with in-house blinding), controlled with Gardasil®, dose-ranging, tolerability, immunogenicity, and efficacy study of a multivalent Human Papillomavirus (HPV) L1 virus-like particle (VLP) vaccine administered to 16-to 26-year-old women. http://www.clinicaltrials.gov/ct2/show/NCT00543543?term= Broad+Spectrum+HPV+%28 Human+Papillomavirus%29+Vaccine+Study+in+ 16-to+26-Year-Old+Women&rank=1 (accessed 4 September 2008).
18. Perrin, K., Daley, E., Naoom, S., Packing-Ebuen, J., Rayko, H., McFarlane, M. et al. (2006). Women's reactions to HPV diagnosis: Insights from in-depth interviews. Women & Health, 43, 93-110.
19. Rogstad, K. E. (2002). The psychological impact of abnormal cytology and colposcopy. British Journal of Obstetrics and Gynaecology, 109, 364-368.
20. Rubin, R. (2007). Vaccines: Mandates or choice? http://www.usatoday.com/ news/health/2007-02-07-vaccines-x.htm (accessed 4 September 2008).
21. Summers, A. (1998). Mental health consequences of cervical screening. Psychology, Health & Medicine, 3, 113-126.
22. Tiro, J. A., Meissner, H. I., Korbin, S., & Chollette, V. (2007). What do women in the U. S. know about Human Papillomavirus and cervical cancer? Cancer Epidemiology Biomarkers & Prevention, 16, 288-294.
23. Vamos, C. A., McDermott, R. J., & Daley, E. M. (2008). The HPV vaccine: Framing the arguments FOR and AGAINST mandatory vaccination of all middle school girls. Journal of School Health, 78, 302-309.
24. Waller, J., McCaffery, K., Kitchener, H., Nazroo, J., & Wardle, J. (2007). Women's experiences of repeated HPV testing in the context of cervical cancer screening: A qualitative study. Psychooncology, 16, 196-204.
25. Wheeler, C. M., Kjaer, S. K., Sigurdsson, K., Iversen, O. E., Hernandez-Avila, M., Perez, G. et al. (2009). The impact of quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. Journal of Infectious Diseases, 199, 936-944.
26. Yacobi, E., Teenant, C., Ferrante, J., Pal, N., & Roetzheim, R. (1999). University students' knowledge and awareness of HPV. Preventive Medicine, 28, 535-541.